Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model
暂无分享,去创建一个
R. Atun | R. Coker | F. Drobniewski | R. Lebcir | Francis Drobniewski | Richard J Coker | Rifat A Atun | Reda Lebcir
[1] P E Fine,et al. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. , 1999, International journal of epidemiology.
[2] T. Frieden,et al. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. , 2002, Bulletin of the World Health Organization.
[3] Y. Balabanova,et al. Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family , 2002, Emerging infectious diseases.
[4] Brian Dangerfield,et al. Optimisation as a statistical estimation tool: an example in estimating the AIDS treatment‐free incubation period distribution , 1999 .
[5] J. Forrester. Industrial Dynamics , 1997 .
[6] D Alland,et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. , 1994, The New England journal of medicine.
[7] R. May,et al. The transmission dynamics of human immunodeficiency virus (HIV). , 1988, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[8] Sonya S. Shin,et al. The dilemma of MDR-TB in the global era. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[9] Christopher Dye,et al. Prospects for worldwide tuberculosis control under the WHO DOTS strategy , 1998, The Lancet.
[10] G W Comstock,et al. The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.
[11] J. Gerberding,et al. Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework , 1998, Journal of Molecular Medicine.
[12] D. Alland,et al. Improved outcomes for patients with multidrug-resistant tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] R. Coker. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[14] Matthew Hickman,et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia , 2002, AIDS.
[15] George P. Richardson,et al. Loop polarity, loop dominance, and the concept of dominant polarity (1984) , 1995 .
[16] R. Coker,et al. Tuberculosis transmission and the impact of intervention on the incidence of infection. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[17] E. Nardell,et al. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. , 2002, Bulletin of the World Health Organization.
[18] R. Coker,et al. Review: Multidrug‐resistant tuberculosis: public health challenges , 2004, Tropical medicine & international health : TM & IH.
[19] S. Blower,et al. Control Strategies for Tuberculosis Epidemics: New Models for Old Problems , 1996, Science.
[20] H. H. Richardson,et al. Introduction to system dynamics , 1967 .
[21] W. Hall,et al. A mathematical model of HIV transmission in NSW prisons. , 1998, Drug and alcohol dependence.
[22] C. Murray,et al. Modeling the impact of global tuberculosis control strategies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Espinal,et al. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] G. Schoolnik,et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.
[25] P. Hopewell,et al. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco. , 1988, The American review of respiratory disease.
[26] Jr Young. Tuberculosis: Case Finding and Chemotherapy: Questions and Answers , 1981 .
[27] P E Fine,et al. Lifetime risks, incubation period, and serial interval of tuberculosis. , 2000, American journal of epidemiology.
[28] Tuberculosis in a rural population of South India: a five-year epidemiological study. , 1974, Bulletin of the World Health Organization.
[29] Nicholas C. Grassly,et al. Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India , 2003 .
[30] B G Williams,et al. Criteria for the control of drug-resistant tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Wallgren. The time-table of tuberculosis. , 1948, Tubercle.
[32] Brian G. Williams,et al. Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis , 2002, Science.
[33] C. Dye,et al. Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru , 2002, The Lancet.
[34] Donna Neuberg,et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. , 2003, The New England journal of medicine.
[35] David N. Ford. A behavioral approach to feedback loop dominance analysis , 1999 .
[36] P. Sonnenberg,et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers , 2001, The Lancet.
[37] P. Kvale,et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. , 1997, American journal of respiratory and critical care medicine.
[38] R. Atun,et al. Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[39] Valerie Isham,et al. Models for Infectious Human Diseases: Their Structure and Relation to Data , 1996 .
[40] L. Karasulu,et al. The treatment of multidrug-resistant tuberculosis in Turkey. , 2001, The New England journal of medicine.
[41] S. Blower,et al. Amplification Dynamics: Predicting the Effect of HIV on Tuberculosis Outbreaks , 2001, Journal of acquired immune deficiency syndromes.
[42] B. Dangerfield,et al. Model-based scenarios for the epidemiology of HIV/AIDS: the consequences of highly active antiretroviral therapy , 2001 .
[43] C. Dye,et al. The resurgence of tuberculosis in Russia. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[44] Timothy R Sterling,et al. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis , 2003, BMJ : British Medical Journal.
[45] K. McAdam,et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[46] C. Guérin,et al. Treatment of Pulmonary Tuberculosis with Isoniazid , 1952 .
[47] Steffen Bayer,et al. Business dynamics: Systems thinking and modeling for a complex world , 2004 .
[48] H. Rieder,et al. Epidemiologic basis of tuberculosis control , 1999 .